Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
twitter

MetaCyc Enzyme: inositol polyphosphate 5-phosphatase K

Gene: INPP5K Accession Number: HS05626 (MetaCyc)

Synonyms: SKIP, skeletal muscle and kidney enriched inositol phosphatase

Species: Homo sapiens

Summary:
General Background

The signalling activities of both D-myo-inositol (1,4,5)-trisphosphate and D-myo-inositol (1,3,4,5)-tetrakisphosphate are terminated by hydrolysis of their 5-phosphate groups. The inositol polyphosphate 5-phosphatases have been subdivided into four subgroups based on their size and substrate specificity [Jefferson97, Erneux98].

Type I enzymes hydrolyze only the water soluble D-myo-inositol (1,4,5)-trisphosphate and D-myo-inositol (1,3,4,5)-tetrakisphosphate [Verjans94, Laxminarayan94].

Type II enzymes also accept the insoluble phospholipids 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate and a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate as substrates [Jefferson95, Jackson95].

Type III enzymes hydrolyze only phosphoinositides and inositol polyphosphates that have a 3-position phosphate group, such as 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate [Jackson95].

Type IV enzymes hydrolyze 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate, 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate, and a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate D-myo-inositol (1,3,4,5)-tetrakisphosphate [Jefferson97]. They do not accept water soluble cyclitols [Kisseleva00].

About This Protein

The cDNA encoding Skeletal muscle and Kidney-enriched Inositol Phosphatase (SKIP) was cloned and expressed in COS-7 cells [Ijuin00]. The gene is ubiquitously expressed and especially abundant in skeletal muscle, heart, and kidney. Baculovirus-expressed recombinant protein exhibited 5-phosphatase activities toward all of the type II substrates including D-myo-inositol (1,4,5)-trisphosphate, D-myo-inositol (1,3,4,5)-tetrakisphosphate, a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate, and 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate. However, affinity towards a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate was 6-fold more than for D-myo-inositol (1,4,5)-trisphosphate [Ijuin00].

The protein localizes to the cytosol in regions lacking actin stress fibers [Ijuin00]. It is thought that this protein may negatively regulate the actin cytoskeleton.

Alternative splicing of this gene results in two transcript variants encoding different isoforms.

Map Position: [1,733,248 <- 1,755,363]

Molecular Weight of Polypeptide: 51.09 kD (from nucleotide sequence)

Unification Links: ArrayExpress:Q9BT40 , Entrez-Nucleotide:AB036829 , Mint:MINT-1445023 , PhosphoSite:Q9BT40 , PhylomeDB:Q9BT40 , Pride:Q9BT40 , Protein Model Portal:Q9BT40 , SMR:Q9BT40 , String:9606.ENSP00000254712 , UniProt:Q9BT40

Relationship Links: InterPro:IN-FAMILY:IPR000300 , InterPro:IN-FAMILY:IPR005135 , Pfam:IN-FAMILY:PF03372 , Smart:IN-FAMILY:SM00128

Gene-Reaction Schematic: ?

Credits:
Created 19-Oct-2009 by Caspi R , SRI International


Enzymatic reaction of: inositol 1,4,5-trisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase K)

EC Number: 3.1.3.56

D-myo-inositol (1,4,5)-trisphosphate + H2O <=> D-myo-inositol (1,4)-bisphosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism , D-myo-inositol (1,4,5)-trisphosphate degradation


Enzymatic reaction of: phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase K)

EC Number: 3.1.3.86

1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O <=> a 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: 3-phosphoinositide degradation


Enzymatic reaction of: inositol-1,3,4,5-tetrakisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase K)

EC Number: 3.1.3.56

D-myo-inositol (1,3,4,5)-tetrakisphosphate + H2O <=> D-myo-inositol (1,3,4)-trisphosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism , D-myo-inositol (1,3,4)-trisphosphate biosynthesis , 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)


Enzymatic reaction of: hosphatidylinositol-4,5-bisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase K)

EC Number: 3.1.3.36

a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O <=> a 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: 3-phosphoinositide degradation

Exons/Introns:


References

Erneux98: Erneux C, Govaerts C, Communi D, Pesesse X (1998). "The diversity and possible functions of the inositol polyphosphate 5-phosphatases." Biochim Biophys Acta 1436(1-2);185-99. PMID: 9838104

Ijuin00: Ijuin T, Mochizuki Y, Fukami K, Funaki M, Asano T, Takenawa T (2000). "Identification and characterization of a novel inositol polyphosphate 5-phosphatase." J Biol Chem 275(15);10870-5. PMID: 10753883

Jackson95: Jackson SP, Schoenwaelder SM, Matzaris M, Brown S, Mitchell CA (1995). "Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase." EMBO J 14(18);4490-500. PMID: 7556092

Jefferson95: Jefferson AB, Majerus PW (1995). "Properties of type II inositol polyphosphate 5-phosphatase." J Biol Chem 270(16);9370-7. PMID: 7721860

Jefferson97: Jefferson AB, Auethavekiat V, Pot DA, Williams LT, Majerus PW (1997). "Signaling inositol polyphosphate-5-phosphatase. Characterization of activity and effect of GRB2 association." J Biol Chem 272(9);5983-8. PMID: 9038219

Kisseleva00: Kisseleva MV, Wilson MP, Majerus PW (2000). "The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase." J Biol Chem 275(26);20110-6. PMID: 10764818

Laxminarayan94: Laxminarayan KM, Chan BK, Tetaz T, Bird PI, Mitchell CA (1994). "Characterization of a cDNA encoding the 43-kDa membrane-associated inositol-polyphosphate 5-phosphatase." J Biol Chem 269(25);17305-10. PMID: 8006039

Lecompte08: Lecompte O, Poch O, Laporte J (2008). "PtdIns5P regulation through evolution: roles in membrane trafficking?." Trends Biochem Sci 33(10);453-60. PMID: 18774718

Rohde02: Rohde G, Wenzel D, Haucke V (2002). "A phosphatidylinositol (4,5)-bisphosphate binding site within mu2-adaptin regulates clathrin-mediated endocytosis." J Cell Biol 158(2);209-14. PMID: 12119359

Verjans94: Verjans B, De Smedt F, Lecocq R, Vanweyenberg V, Moreau C, Erneux C (1994). "Cloning and expression in Escherichia coli of a dog thyroid cDNA encoding a novel inositol 1,4,5-trisphosphate 5-phosphatase." Biochem J 300 ( Pt 1);85-90. PMID: 8198557

Zhang07c: Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS (2007). "Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice." Proc Natl Acad Sci U S A 104(44);17518-23. PMID: 17956977


Report Errors or Provide Feedback
Please cite the following article in publications resulting from the use of MetaCyc: Caspi et al, Nucleic Acids Research 42:D459-D471 2014
Page generated by SRI International Pathway Tools version 18.5 on Fri Nov 28, 2014, biocyc14.